Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?

International Journal of Clinical and Experimental Medicine

Volumn 4, Issue 3, 2011, Pages 179-186

  de Paiva, Nielce M ^a   Ayrizono, Maria L S ^a   Milanski, Marciane ^a   Coope, Andressa ^a   Oliveira, Luiza M F ^a   Fagundes, João J ^a   Velloso, Lício A ^a   Coy, Cláudio S R ^a   Leal, Raquel F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytokines; Familial adenomatous polyposis; Ileal pouch; Pouchitis; Toll like receptors; Ulcerative colitis

Indexed keywords

BACTERIAL ANTIGEN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADENOMATOUS POLYP; ADULT; ARTICLE; ASYMPTOMATIC INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM MUCOSA; ILEUM POUCH; IMMUNOBLOTTING; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ULCERATIVE COLITIS;

BACTERIA (MICROORGANISMS);

EID: 80053596327     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Wu H, Shen B. Pouchitis: Lessons for inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25: 314-322.
2. Mc Guire BB, Brannigan AE, O'Connell PR: Ileal pouch-anal anastomosis. Br J Surg 2006; 94: 812-823.
3. Leal RF, Ayrizono ML, Milansk M, Coope, Fagundes JJ, Velloso LA, Coy CSR. Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gama and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. Clin Exp Immunol 2010; 160: 380-385.
4. Heuschen UA, Allemeyer EH, Hinz U, Autschbach F, Uehlein T, Herfarth C, Heuschen G: Diagnosing pouchitis: comparative validation of two scoring system in routine follow-up. Dis Colon Rectum 2002; 45: 776-786.
5. Shen B, Fazio VW, Renzi FH, Brzezinski A, Bennett AE, Lopez R, Hammel JP, Achkar JP, Bevins CL, Lavery IC, Strong SA, Delaney CP, Liu W, Bambrick ML, Sherman KK, Lashner BA: Risk factors for disease of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2006; 4: 81-89.
6. Ohge H, Furne JK, Springfield J, Rothenberger DA, Madoff RD, Levitt MD: Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005; 48: 469-475.
7. Yamamoto T, Umegae S, Kitagawa T, Matsumoto K: The impact of the fecal stream and stasis on immunologic reactions in ileal pouch after restorative proctocolectomy for ulcerative colitis: a prospective, pilot study. Am J Gastroenterol 2005; 100: 2248-2253.
8. Sartor RB. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol 2003; 19: 358-365.
9. Wu H, Shen B. Pouchitis and pouch dysfunction. Gastroenterol Clin N Am 2009; 38: 651-668.
10. D'Incà R, Barollo M, Scarpa M, Grillo AR, Brun P, Vettorato MG, Castagliuolo I, Sturniolo GC. Rectal administration of lactobacillus casei DG modifies flora composition and Toll-Like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig Dis Sci 2011; 56: 1178-1187.
11. Bambury N, Coffey C, Burke, Redmond P, Kirwan WO. Sulphomucin expression in ileal pouches: Emerging differences between ulcerative colitis and familial adenomatous polyposis pouches. Dis Colon Rectum 2008; 51: 561-567.
12. Liu G, Zhang L, Zhao Y. Modulation of immune responses through direct activation of Toll-like receptors to T cells. Clin Exp Immunol 2010; 160: 168-175.
13. Bekeredjian-Ding I, Jego G. Toll-like receptors -sentries in the B-cell response. Immunology 2009; 128: 311-323.
14. Gribar SC, Anand RJ, Sodhi CP, Hackam DJ. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol 2008; 83: 493-498.
15. Peri F, Piazza M, Calabresei V, Damore G, Cighetti R. Exploring the LPS/TLR4 signal pathway with small molecules. Biochem Soc Trans 2010; 38: 1390-1395.
16. Karin M, Gallagher E. From JNK to pay dirt: Jun Kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005; 57: 283-295.
17. Vora P, Youdim A, Thomas LS, Fukata M, Tesfay SY, Lukasek K, Michelsen KS, Wada A, Hirayama T, Arditi M, Abreu AT. Defensin-2 expression is regulated by TLR Signaling in intestinal epithelial cells. J Immunol 2004; 173: 5398-5405.
18. Cantó E, Ricart E, Monfort D, González-Juan D, Balanzó J, Rodríguez-Sánchez JL, Vidal S. TNF alpha production to TLR2 ligands in active IBD patients. Clin Immunol 2006; 119: 156-165.
19. Fukata M, Abreu MT. TLR4 signalling in the intestine in health and disease. Biochem Soc Trans 2007; 35: 1473-1478.
20. Wei J, Feng J. Signaling pathways associated with inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov 2010; 4: 105-117.
21. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010-7017.
22. Singh JC, Cruickshank SM, Newton DJ, Wakenshaw L, Graham A, Lan J, Lodge JP, Felsburg PJ, Carding SR. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. Am J Physiol Gastrointest Liver Physiol 2005; 288: G514-524.
23. Ey B, Eyking A, Gerken G, Podolsky DK, Cario E. TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. J Biol Chem 2009; 284: 22332-22343.
24. Lee JH, Lee B, Lee HS, Bae EA, Lee H, Ahn YT, Lim KS, Huh CS, Kim DH. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis 2009; 24: 231-237.
25. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004; 112: 85-91.
26. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Devière J, Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004; 53: 987-992.
27. Lammers KM, Ouburg S, Morré SA, Crusius JBA, Gionchetti P, Rizzello F, Morselli C, Caramelli E, Conte R, Poggioli G, Campieri M, Pena AS. Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol 2005; 11: 7323-7329.
28. Toiyama Y, Araki T, Yoshiyama S, Hiro JI, Miki C, Kusunoki M. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today 2006; 36: 287-290.
29. Heuschen G, Leowardi C, Hinz U, Autschbach F, Stallmach A, Herfarth C, Heuschen UA. Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients. Int J Colorectal Dis 2007; 22: 293-301.
30. Góes JRN, Coy CSR, Amaral CA, Fagundes JJ, Medeiros R. Superior mesenteric artery syndrome as a complication of ileal pouch-anal anastomosis. Dis Colon Rectum 1995; 38: 543-544.
31. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis disease activity index. Mayo Clin Proc 1994; 69: 409-415.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
33. Velloso LA, Folli F, Sun XJ, White MF, Saad MJA, Kahn CR. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 1996; 93: 12490-12495.
34. Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, Jahn HK, Freudenberg M, Loddenkemper C, Batra A, Lehr HA, Liesenfeld O, Blaut M, Göbel UB, Schumann RR, Bereswill S. Shift towards proinflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One 2007; 25; 2: e662.
35. Liu Y, Zhang Z, Wang L, Li J, Dong L, Yue W, Chen J, Sun X, Zhong L, Sun D. TLR4 monoclonal antibody blockade suppresses dextransulfate-sodium-induced colitis in mice. J Gastroenterol Hepatol 2010; 25: 209-214.
36. Kiehne K, Brunke G, Wegner F, Banasiewicz T, Folsch UR, Herzig KH. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006; 21: 12: 1056-1062.
37. Gionchetti P, Campieri M, Belluzzi A, Bertinelli E, Ferretti M, Brignola C, Poggioli G, Miglioli M, Barbara L: Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci 1994; 39: 1525-1531.
38. Bulois P, Tremaine WJ, Maunoury V, Gambiez L, Hafraoui S, Leteurtre E, Cortot A, Sandborn WJ, Colombel JF, Desreumaux P: Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 2000; 6: 157-167.
39. Leal RF, Coy CS, Ayrizono ML, Fagundes JJ, Milanski M, Saad MJ, Velloso LA, Góes JR. Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. Tech Coloproctol 2008; 12: 33-38.
40. Kühbacher T, Gionchetti P, Hampe J, Helwig U, Rosenstiel P, Campieri M, Buhr HJ, Schreiber S. Activation of signal-transducer and activator of transcription 1(STAT1) in pouchitis. Clin Exp Immunol 2001; 123: 395-401.
41. Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 2008; 14: 5115-5124.
42. Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of Tregulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 2008; 125: 145-153.
43. Rahman FZ, Smith AM, Hayee B, Marks DJ, Bloom SL, Segal AW. Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4. PLoS One 2010; 5: e9891.
44. Stanislawowski M, Wierzbicki PM, Golab A, Adrych K, Kartanowicz D, Wypych J, Godlewski J, Smoczynski M, Kmiec Z. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients. J Physiol Pharmacol 2009; 60: 71-75.
45. McDonnell M, Liang Y, Noronha A, Coukos J, Kasper DL, Farraye FA, Ganley-Leal LM. Systemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel ease. Inflamm Bowel Dis 2011; 17: 298-307.
46. Mitsuyama K, Suzuki A, Tomiyasu N, Tsuruta O, Kitazaki S, Takeda T, Satoh Y, Bennett BL, Toyonaga A, Sata M. Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease. Int J Mol Med 2006; 17: 449-455.
47. Roy PK, Rashid F, Bragg J, Ibdah JA. Role of the JNK signal transduction pathway in inflammatory bowel disease. World J Gastroenterol 2008; 14: 200-202.